Perspective Inventory Turnover from 2010 to 2024

CATX Stock   3.47  0.47  15.67%   
Perspective Therapeutics Inventory Turnover yearly trend continues to be fairly stable with very little volatility. Inventory Turnover will likely drop to 4.24 in 2024. Inventory Turnover is a ratio showing how many times a company's inventory is sold and replaced over a period, indicating the efficiency of inventory management. View All Fundamentals
 
Inventory Turnover  
First Reported
2010-12-31
Previous Quarter
4.46
Current Value
4.24
Quarterly Volatility
5.19389652
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Perspective Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Perspective Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 459.3 K, Total Revenue of 0.0 or Gross Profit of 1.3 M, as well as many indicators such as Price To Sales Ratio of 57.93, Dividend Yield of 0.0 or PTB Ratio of 5.49. Perspective financial statements analysis is a perfect complement when working with Perspective Therapeutics Valuation or Volatility modules.
  
Check out the analysis of Perspective Therapeutics Correlation against competitors.
For more information on how to buy Perspective Stock please use our How to Invest in Perspective Therapeutics guide.

Latest Perspective Therapeutics' Inventory Turnover Growth Pattern

Below is the plot of the Inventory Turnover of Perspective Therapeutics over the last few years. It is a ratio showing how many times a company's inventory is sold and replaced over a period, indicating the efficiency of inventory management. Perspective Therapeutics' Inventory Turnover historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Perspective Therapeutics' overall financial position and show how it may be relating to other accounts over time.
Inventory Turnover10 Years Trend
Slightly volatile
   Inventory Turnover   
       Timeline  

Perspective Inventory Turnover Regression Statistics

Arithmetic Mean9.24
Geometric Mean8.09
Coefficient Of Variation56.21
Mean Deviation3.85
Median8.05
Standard Deviation5.19
Sample Variance26.98
Range19.7583
R-Value(0.83)
Mean Square Error9.09
R-Squared0.69
Significance0.0001
Slope(0.96)
Total Sum of Squares377.67

Perspective Inventory Turnover History

2024 4.24
2023 4.46
2022 3.88
2021 4.43
2020 5.03
2019 7.06
2018 8.05

About Perspective Therapeutics Financial Statements

Perspective Therapeutics investors use historical fundamental indicators, such as Perspective Therapeutics' Inventory Turnover, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Perspective Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Inventory Turnover 4.46  4.24 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Perspective Stock Analysis

When running Perspective Therapeutics' price analysis, check to measure Perspective Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Perspective Therapeutics is operating at the current time. Most of Perspective Therapeutics' value examination focuses on studying past and present price action to predict the probability of Perspective Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Perspective Therapeutics' price. Additionally, you may evaluate how the addition of Perspective Therapeutics to your portfolios can decrease your overall portfolio volatility.